Skip to main content

Table 4 Neurological and mental disorder diagnoses and medication on discharge and 12-month post-discharge follow-up outcome regarding movement disturbances and mental disorder- and neurological diagnoses

From: Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series

Case No Hospitalization duration (in days) Discharge neurological diagnosis Discharge mental disorder diagnosis Medication at discharge 12-month post-discharge follow-up outcome
1 45 Drug-induced parkinsonism
Mild Cognitive Impairment due to Alzheimer’s disease
Organic mood disorder Duloxetine (90), donepezil (5) No movement disturbances
Dementia due to Alzheimer’s disease
2 40 Idiopathic tremor Severe depressive episode of recurrent depressive disorder Quetapine (25), duloxetine (60),
clonazepam (2),
levothyroxine sodium (100 μg)
Idiopathic tremor
3 90 Drug-induced parkinsonism Severe depressive episode of recurrent depressive disorder Risperidone (4),
paroxetine (20), mirtazapine (60), alprazolam (4), biperiden (4)
No movement disturbances
4 120 Drug-induced parkinsonism
Tardive dyskinesia
Mild Cognitive Impairment due to Alzheimer’s disease
Severe depressive episode of recurrent depressive disorder Quetiapine (150), trazodone (50), mirtazapine (45), lorazepam (7.5), biperiden (2), pindolol (5) Tardive dyskinesia
Dementia due to Alzheimer’s disease
5 60 Drug-induced parkinsonism Organic mood disorder Quetiapine (50), duloxetine (90), lorazepam (0.5),
levodopa/benserazide (100/25),
amiloride, hydrochloride/hydrochlorothiazide (5/50)
Parkinsonism
Persistent psychotic symptoms
6 35 Parkinson’s disease Organic mood disorder Escitalopram (40), lorazepam (1),
levodopa/benserazide (600/150), amantadine (100)
Parkinsonism
7 100 Drug-induced parkinsonism Severe depressive episode of recurrent depressive disorder Duloxetine (60),
mirtazapine (45),
lorazepam (1),
levodopa/benserazide (200/50)
No movement disturbances
Dementia due to Alzheimer’s disease
8 40 Vascular parkinsonism
Microvascular ischemic brain disease
Organic mood disorder Duloxetine (30), rivastigmine (4.6), levodopa/benserazide (200/50), ilbesartan (150) Parkinsonism
Vascular dementia